Abstract
Treatment of the upper face with botulinum toxin A (BTX-A) has set a new standard against which all other esthetic procedures are measured. Although the first published report of BTX application in the face appeared only in 1990, a number of clinicians were already exploring the upper face uses during the late 1980s, enthused by its obvious benefits and safety.1
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Operative Techniques in Otolaryngology - Head and Neck Surgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
